Drugmaker Adcock Ingram full-year HEPS falls marginally
JOHANNESBURG, Aug 26 (Reuters) - South Africa's Adcock Ingram Holdings Ltd AIPJ.J on Wednesday posted a marginal decrease of 1% in annual headline earnings per share (HEPS) and scrapped its dividend for the year.
HEPS, the main profit measure for companies in South Africa, came in at 417.5 South African cents ($0.2483) for the year to June 30.
The drugmaker was declared essential service during the lockdown imposed in South Africa from March-end to curb the spread of the coronavirus.
(Reporting by Promit Mukherjee; Editing by Subhranshu Sahu)
((firstname.lastname@example.org; +27 64833 4448;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Latest World Markets Videos
- ANALYSIS-Putin draws Erdogan a red line on Russia's southern flank with Karabakh deal
- JPMorgan warns 10% of junk-rated emerging markets facing debt crises this year
- The Poorest Nations in the World: 5 Countries With the Lowest Per Capita Income
- Ancient massive 'Dragon of Death' flying reptile dug up in Argentina